Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial

Lancet

Volumn 351, Issue 9105, 1998, Pages 793-796

  Cascinelli, N ^a,d   Morabito, A ^b   Santinami, M ^a   Mackie, R M ^c   Belli, F ^d  

^a Casa di Cura S Pio X ^*  (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; WORLD HEALTH ORGANIZATION;

EID: 0032515763     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)08260-3     Document Type: Article

References (13)

1. 1 Balch CM, Soong S-J, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224: 255-66.
2. 2 Veronesi U. Efficacy of immediate node dissection of stage I melanoma. N Engl J Med 1977; 2: 627-30.
3. 3 Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982; 49: 2420-30.
4. 4 Sim FH, Taylor WF, Ivins JC, et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 1978; 41: 948-56.
5. 5 Cascinelli N. The role of clinical trials in assessing optimal treatment of cutaneous melanoma not extending beyond the regional nodes. Eur J Surg Oncol 1996; 22: 123-33.
6. 6 Balch CM, Milton GW, Cascinelli N, et al. Elective lymph node dissection: pros and cons. In: Balch CM, Houghton A, Milton GW, et al (eds). Cutaneous melanoma. 2nd edn. Philadelphia: Lippincott, 1992: 345-66.
7. 7 Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-99.
8. 8 Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 756-67.
9. 9 Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-60.
10. 10 Kapteijn BAE, Nieweg OE, Liem IH, et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156-60.
11. 11 Ross MI. Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin. Semin Surg Oncol 1996; 12: 394-401.
12. 12 Gershenwald J, Thompson W, Mansfield P, et al. Patterns of failure in melanoma patients after successful lymphatic mapping and negative sentinel node biopsy. In: abstract book of 48th annual cancer symposium of the Society of Surgical Oncology, March 21-24, 1996, Atlanta. Arlington Heights: Society of Surgical Oncology, 1996: 20 abstr.
13. 13 MacKie RM, Byrno D, Lingam HR, et al. Prognostic evaluation of sentinel node biopsy. Melanoma Res 1997; 7 (suppl 1): S102.